Company intelligence / Profile preview

Pillars

Natick, Massachusetts, United Statespillarscommunityhealth.org ↗

Ownership: Private
Development stage: Other

Overview

Pillar Biosciences develops and commercializes next-generation sequencing (NGS) diagnostic solutions for precision oncology. Their proprietary technologies enable rapid, accurate genomic profiling of tumors to guide therapy selection. The company has received FDA approval for its oncoReveal® CDx Pan-Cancer Solid Tumor IVD Kit and offers over 20 NGS testing kits globally. Recent funding rounds have supported expansion of their product portfolio and biopharma partnerships.

Therapeutic areas: Oncology
Modalities: Diagnostic kit (NGS-based)Next-generation sequencing technology platform
Industry: Molecular Diagnostics

Partnerships

Illumina (strategic investment & co-marketing agreements)Hamilton Companymultiple biopharma collaborations

Beyond the preview

Go deeper on Pillars.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pillars.

Explore the full profile